John Phillip Ragard's most recent trade in Aspira Women`s Health Inc was a trade of 4,844 Restricted Stock Units done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 4,844 | 0 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 4,844 | 134,734 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,843 | 4,844 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,843 | 129,890 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 4,844 | 9,687 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 4,844 | 125,047 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 4,844 | 14,531 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 4,844 | 120,203 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 4,844 | 14,531 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 4,844 | 120,203 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | John Phillip Ragard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2024 | 19,375 | 19,375 | - | - | Restricted Stock Units |